- Home
- XP vs ELAN Comparison
XP vs ELAN Comparison
Compare XP & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XP | ELAN |
|---|---|---|
| Founded | 2001 | 1954 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.7B |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XP | ELAN |
|---|---|---|
| Price | $19.55 | $22.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $23.17 | ★ $27.89 |
| AVG Volume (30 Days) | ★ 5.2M | 4.0M |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $19.00 | $8.21 |
| Revenue Next Year | $13.64 | $5.31 |
| P/E Ratio | $11.42 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $15.51 | $9.26 |
| 52 Week High | $23.13 | $27.72 |
Technical Indicators
Market Signals| Indicator | XP | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 39.87 |
| Support Level | $18.58 | $22.17 |
| Resistance Level | $20.42 | $23.16 |
| Average True Range (ATR) | 0.75 | 0.82 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 37.45 | 19.70 |
Price Performance
Historical ComparisonAbout XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.